Steven Grant

1.2k total citations
27 papers, 935 citations indexed

About

Steven Grant is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Steven Grant has authored 27 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Steven Grant's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (5 papers) and Biochemical and Molecular Research (3 papers). Steven Grant is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (5 papers) and Biochemical and Molecular Research (3 papers). Steven Grant collaborates with scholars based in United States, United Kingdom and Belgium. Steven Grant's co-authors include Curt R. Freed, George R. Uhl, Michael J. Kuhar, Roxanne A. Vaughan, A.J. Porter, William J. Harris, W. David Jarvis, Robert P. Friedland, Ivan M. Roitt and David A. Gewirtz and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and The Journal of Comparative Neurology.

In The Last Decade

Steven Grant

27 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Grant United States 14 491 180 147 141 118 27 935
Paola Mina‐Osorio United States 19 407 0.8× 179 1.0× 383 2.6× 53 0.4× 222 1.9× 38 1.7k
Luping Shen United States 16 785 1.6× 238 1.3× 129 0.9× 70 0.5× 145 1.2× 29 1.5k
Michael J. Dobersen United States 20 460 0.9× 177 1.0× 77 0.5× 218 1.5× 321 2.7× 35 1.5k
Julia Heinrich United States 16 664 1.4× 124 0.7× 128 0.9× 258 1.8× 297 2.5× 32 1.1k
Maarten Van Roy Belgium 9 344 0.7× 48 0.3× 176 1.2× 263 1.9× 218 1.8× 16 849
Doris Gundersen Norway 24 653 1.3× 102 0.6× 77 0.5× 54 0.4× 132 1.1× 34 1.7k
Jessica A. Couch United States 15 405 0.8× 63 0.3× 151 1.0× 282 2.0× 226 1.9× 22 1.1k
Alla L. Zozulya Germany 21 329 0.7× 155 0.9× 238 1.6× 52 0.4× 710 6.0× 30 1.4k
Paola Gasperini United States 19 370 0.8× 146 0.8× 393 2.7× 24 0.2× 186 1.6× 26 970
Dongmin Dang United States 18 425 0.9× 93 0.5× 229 1.6× 41 0.3× 84 0.7× 29 994

Countries citing papers authored by Steven Grant

Since Specialization
Citations

This map shows the geographic impact of Steven Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Grant more than expected).

Fields of papers citing papers by Steven Grant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Grant. The network helps show where Steven Grant may publish in the future.

Co-authorship network of co-authors of Steven Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Grant. A scholar is included among the top collaborators of Steven Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Grant. Steven Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Steven, et al.. (2024). Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos. PLoS Genetics. 20(6). e1011308–e1011308. 2 indexed citations
2.
Yamniuk, Aaron P., Anish Suri, Stanley R. Krystek, et al.. (2016). Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope. Journal of Molecular Biology. 428(14). 2860–2879. 12 indexed citations
3.
Yamniuk, Aaron P., James Tamura, Steven Grant, et al.. (2013). An Anti-CD154 Domain Antibody Prolongs Graft Survival and Induces Foxp3+ iTreg in the Absence and Presence of CTLA-4 Ig. American Journal of Transplantation. 13(11). 3021–3030. 37 indexed citations
4.
Younson, Justine, Rachel O’Mahony, Steven Grant, et al.. (2009). A Human Domain Antibody and LewisbGlycoconjugate That Inhibit Binding ofHelicobacter pylorito LewisbReceptor and Adhesion to Human Gastric Epithelium. The Journal of Infectious Diseases. 200(10). 1574–1582. 8 indexed citations
5.
Newell, John, et al.. (2008). Fluid and electrolyte balance in elite gaelic football players.. PubMed. 101(8). 236–9. 9 indexed citations
6.
Bernardis, Flavia De, Rachel O’Mahony, Roberto La Valle, et al.. (2006). Human Domain Antibodies against Virulence Traits ofCandida albicansInhibit Fungus Adherence to Vaginal Epithelium and Protect against Experimental Vaginal Candidiasis. The Journal of Infectious Diseases. 195(1). 149–157. 91 indexed citations
7.
Ferrick, Michael G., et al.. (2005). Soil Freeze-Thaw Effects on Bank Erosion and Stability: Connecticut River Field Site, Norfolk, Vermont. Defense Technical Information Center (DTIC). 1 indexed citations
8.
Harvey, S., R. H. Decker, Yun Dai, et al.. (2001). Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.. PubMed. 7(2). 320–30. 20 indexed citations
9.
Grant, Steven. (2000). Physical and Chemical Factors Affecting Contaminant Hydrology in Cold Environments. US Army Corps of Engineers: Engineer Research and Development Center (Knowledge Core). 2 indexed citations
10.
Dooley, Helen, Steven Grant, William J. Harris, & A.J. Porter. (1998). Stabilization of antibody fragments in adverse environments. Biotechnology and Applied Biochemistry. 28(1). 77–83. 33 indexed citations
11.
Strachan, Gillian, et al.. (1998). Binding characteristics of anti-atrazine monoclonal antibodies and their fragments synthesised in bacteria and plants.. Biosensors and Bioelectronics. 13(6). 665–673. 27 indexed citations
12.
13.
Grant, Steven. (1997). Ara-C: Cellular and Molecular Pharmacology. Advances in cancer research. 72. 197–233. 223 indexed citations
14.
Mikkelsen, Ross B., et al.. (1996). Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.. PubMed. 10(7). 1150–8. 15 indexed citations
15.
Grant, Steven, et al.. (1995). Expression of Monovalent and Bivalent Antibody Fragments in Escherichia coli. Journal of Hematotherapy. 4(5). 383–388. 6 indexed citations
16.
Freed, Curt R., et al.. (1995). Dopamine transporter immunoreactivity in rat brain. The Journal of Comparative Neurology. 359(2). 340–349. 204 indexed citations
17.
Molloy, Peter, et al.. (1995). Expression and purification strategies for the production of single-chain antibody and T-cell receptor fragments inE. coli. Molecular Biotechnology. 4(3). 239–245. 4 indexed citations
18.
Schmidt‐Ullrich, Rupert, et al.. (1994). Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.. PubMed. 66(6). 775–83. 5 indexed citations
19.
Grant, Steven, Rebecca S. Traylor, George R. Pettit, & Peck‐Sun Lin. (1993). Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors. Cytokine. 5(5). 490–497. 5 indexed citations
20.
Grant, Steven, et al.. (1992). Effects of bryostatin 1 and rGM‐CSF on the metabolism of 1‐β‐d‐arabinofuranosylcytosine in human leukaemic myeloblasts. British Journal of Haematology. 82(3). 522–528. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Mina‐Osorio Breakdown of academic impact, for papers by Luping Shen Breakdown of academic impact, for papers by Michael J. Dobersen Breakdown of academic impact, for papers by Julia Heinrich Breakdown of academic impact, for papers by Maarten Van Roy Breakdown of academic impact, for papers by Doris Gundersen Breakdown of academic impact, for papers by Jessica A. Couch Breakdown of academic impact, for papers by Alla L. Zozulya Breakdown of academic impact, for papers by Paola Gasperini Breakdown of academic impact, for papers by Dongmin Dang
Rankless by CCL
2026